SK Bioscience is one of Korea's largest vaccine manufacturers. The company is pursuing its own COVID-19 vaccine and is collaborating with global biotech companies to produce components for a coronavirus vaccine.
During the meeting the parties exchanged views on the latest trends in the bio-pharmaceutical industry, emphasized the importance of having national infrastructures to produce vaccines, and discussed possible ways of cooperation, including in the field of research.
They also discussed a possibility of partnerships between companies from different countries in the production of vaccines.
